TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

23 hedge funds and large institutions have $9.91M invested in Trillium Therapeutics Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AFM
1
Anson Funds Management
Texas
$298K
2
Morgan Stanley
2
Morgan Stanley
New York
$894K
3
OAM
3
Oxford Asset Management
United Kingdom
$98K
4
Jane Street
4
Jane Street
New York
$43K
5
Citadel Advisors
5
Citadel Advisors
Florida
$40K

Top Sellers

1
AIC
1
AWM Investment Company
New York
$0
2
CAM
2
Cormorant Asset Management
Massachusetts
$0
3
SLG
3
Stanley-Laman Group
Pennsylvania
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$0
5
CS
5
Candriam SCA
Luxembourg
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
26
Renaissance Technologies
New York
– -$673K -116,100 Closed
CS
27
Candriam SCA
Luxembourg
– -$538K -94,000 Closed
Deutsche Bank
28
Deutsche Bank
Germany
– -$493K -85,057 Closed
Creative Planning
29
Creative Planning
Kansas
– -$170K -29,300 Closed
WAAG
30
Wealth Alliance Advisory Group
Kansas
– -$126K -21,800 Closed
Russell Investments Group
31
Russell Investments Group
United Kingdom
– -$33K -5,614 Closed
TRCT
32
Tower Research Capital (TRC)
New York
– -$3K -547 Closed
1
2